The power of an international network.
Telemedicine Technologies brings together an international network of CROs around its CleanWEB solution (EDC, IWRS, ePRO, eCOA, eTMF, CTMS, CDMS …).
Conduct your international studies. The use of the same technological platform makes it possible to standardize the data collection processes on all the countries covered by the CRO-Alliance, while benefiting from the perfect knowledge of the environment specific to each country in which the CRO-Alliance members operate.
CleanWEB, an innovative and fully validated solution that enables CRO-Alliance customers to respond safely to the new challenges of clinical research: centralized monitoring, real life testing and compliance monitoring, epidemiological registers, implementation Patient Support Programs (PSP) …
The Tech Alliance ecosystemCleanWEB provides CRO-Alliance customers with a unique set of innovative, optional, previously selected, integrated and validated technological devices: studies with mobile ePRO and / or connected medical devices (eCOA).
A common quality management system. Alliance members benefit from the same training and skills transfer program from Telemedicine Technologies, guaranteeing the perfect control of the technological platform and a common quality management system (performance indicators, Standard operating procedures, level of service commitments, internal audit system, etc.).
A unique shop: whatever the size of the clinical study (geographical coverage, scope of services required), the CRO-Alliance is able to offer a single contact point to facilitate the contractual management of your project while providing guarantees And Service Level Agreements (SLAs)
CleanWEB Academy :a unique and exclusive framework for CRO-Alliance members to share knowledge on new market expectations, updates to the CleanWEB platform and its “TECH-Alliance” extensions, Continuous improvement of the quality and services supply.
The CRO-Alliance partners
Founded in 2006 in France, AB Cube has been the pioneer of SaaS in providing the international healthcare industry with vigilance software solutions for management of adverse events. And now, they have launched a multivigilance cloud-based solution, SafetyEasy® Suite.
To address the challenges of international safety regulations including combination product reporting, through SafetyEasy® SuiteAB-Cube offers a wide range of dedicated solutions like pharmacovigilance, medical device safety, nutrivigilance and CosmEthics®for cosmetovigilance.
AB Cube believes in the power of SaaS
Always one step ahead, the company truly believes in the power of SaaS which allows us to be flexible and compliant. In November 2017, AB Cube were fully E2B (R3) native and so were all its clients.
Not only the systems are easy to use, quickly installed and fully evolutive but also AB Cube vigilance solutions are all validated according to GAMP 5 and FDA 21 CFR part 11.
Axonal-Biostatem has been delivering top-notch management of clinical and epidemiological research projects in France and Europe for 30 years.
Axonal-Biostatem is a full service CRO providing all services internally and able to integrally perform a study from protocol design to publication of results.
Axonal-Biostatem supports the medicinal and medical device industries as well as academic sponsors in the management of clinical trials and studies (Phases I to IV, early phase study, early access program, trials for reimbursement, post inscription studies), pharmaco-epidemiological studies, surveys and observatories.
Bluecompanion ltd, is a SME specialized in Clinical Trials, Regulatory Science and large partnerships in Multidisciplinary Projects. It operates in the UK and in the EU countries, as well in the US.
Since 2015 Bluecompanion is collaborating with SPRINTT, an IMI funded integrated clinical project in geriatrics (scientific and regulatory strategy); and more recently with SARA, a Biophytis sponsored development program in age-related sarcopenia (integrated digital platform and devices).
“We believe Patient’s friendly interfaces and adapted devices are key for successful innovative methodologies in clinical research.”
The CERC is a unique Contract Research Organization based in Massy, France, and presided by four medical directors, Dr. Marie-Claude Morice, Dr. Philip Urban, Dr. Davide Capodanno and Dr. Philippe Garot.
The CERC was created with the aim of establishing a reputable high-quality dedicated cardiovascular CRO in Europe. Its objectives are to underpin European clinical trials and academic leadership, act as a global CRO and support young scientific leaders.
The prestigious members of the CERC’s Medical Advisory Council provide unparalleled guidance and expert support in a broad range of clinical trials dedicated to the assessment of interventional coronary and peripheral revascularization, structural and valvular heart disease treatments and adjunctive pharmacology.
The CERC has an excellent track record in regulatory guidance, trial design, global study management and monitoring, CEC/DSMB coordination, core-lab activities , presentations in meetings and publications for pre- and post- market drug and device trials.
The CERC’s industrial partners attach great importance to finding cost-effective models which do not compromise quality.
NEXTCRO is a UK based Contract Research Organisation (CRO) with offices and operations in Greece and Turkey.
NEXTCRO proposes high quality solutions to its customers in adapting the new European legislation, offering risk management and remote monitoring, meeting high sponsor’s expectations, fast start-up timelines and agreeing on KPIs with customers, having dedicated teams and sharing all necessary information with customers’ teams regarding the territory.
NEXTCRO’s team combines international experience with local expertise and geographical presence. Our highly skilled team offers plug and play solutions as soon as a new study includes sites in Greece and Turkey.
We think and do it different: we will be sharing our vision, values and working practices to secure efficient and successful delivery.
NEXTCRO is your next clinical trials partner in Greece and Turkey.
POPSICUBE is an international CRO with offices in France, the USA and China, as well as a global network of selected local CRO partners to manage global projects.
POPSICUBE offers clinical services combining first class quality requirements with cost efficiency for the Pharmaceutical Industry, Medtechs, Biotechs, Diagnostic, lVet Pharma, Cosmetics and Dietary supplements companies.
POPSICUBE can cover the whole value chain of clinical development, from the joint definition of the strategy up to the regulatory approval.
Agile and innovative solutions
Relying on many years of experience within large Pharmaceutical Laboratories and CROs, POPSICUBE allies in-depth knowledge of research and clinical development with a unique know-how of IT tools, to create proven benefits for your clinical projects. POPSIPEN© is a unique digital pen and paper solution specially designed for clinical research.
More than 120 customers, including 6 in the top 10 pharma and 2 in the top 5 CROs, have chosen POPSICUBE for their clinical projects.